E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Preferred drug usage among patients attending ophthalmology outpatient department for the treatment of dry eye syndrome in a tertiary care teaching hospital at Dehradun, Uttarakhand

Shaktibala Dutta, Mirza Atif Beg, Shalu Bawa, Saubhagya Sindhu, Mohammad Anjoom, Sanjeev Kumar Mittal, Yogesh Kumar, Ankita Negi.

Abstract
Background: Prescription auditing studies are a part of drug use studies and are beneficial in clinical practice for rational prescribing of drugs and helpful for minimizing the medication errors. These are an important tool to promote rational prescribing.

Aims and Objectives: To study the drug-prescribing pattern in patients with dry eye syndrome.

Materials and Methods: A drug use study was conducted in dry eye patients by the Department of Pharmacology, Shri Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, for 1 year. A total of 393 prescriptions were evaluated for prescribing pattern by using WHO drug use indicators.

Results: Of the 393 prescriptions analyzed, it was found that 852 drugs were prescribed: 484 (56.81%) were artificial tears, 160 (18.78%) non-steroidal anti-inflammatory drugs (NSAIDs), 152 (17.84%) steroids, and 56 (6.57%) belonged to “others” category. Carboxymethyl cellulose, hydoxypropyl cellulose, and polyethylene glycol were the most common artificial tears prescribed. Prescribed NSAIDs included ketorolac, bromofenac, and diclofenac whereas fluromethalone, loteprednol, and difluprednate were the most commonly prescribed steroids for the treatment of dry eye. It was found that 0.7% fixed-dose combinations (FDCs) were prescribed; 2.24 drugs were prescribed per prescription; and 56.10% drugs were prescribed from National Essential Medicine List.

Conclusion: Artificial tears were the most commonly prescribed drugs for dry eye. A therapeutic audit to provide regular feedback to researchers and prescribers may encourage rational prescribing in dry eye disease.

Key words: Drug Use; Rational Prescribing; Fixed-Dose Combinations; Therapeutic Audit; Dry Eye Patients


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Shaktibala Dutta
Articles by Mirza Atif Beg
Articles by Shalu Bawa
Articles by Saubhagya Sindhu
Articles by Mohammad Anjoom
Articles by Sanjeev Kumar Mittal
Articles by Yogesh Kumar
Articles by Ankita Negi
on Google
on Google Scholar


REFERENCES
1. Djalilian AR, Hamrah P, Pflugfeder SC. Dry Eye Eye. In: Krachmer JH, Mannis MJ, Holland EJ (Eds.), Cornea: Fundamentals, Diagnosis and Management, 2nd edn, New York: Elsevier Mosby, 2005. pp. 521–40.
2. Diseases of the Conjunctiva. In: Sihota R, Tandon R (Eds.), Parson's Diseases of the Eye, 21st edn, India: Elsevier, 2011. pp. 185–6.
3. Epidemiology Subcommittee of the International Dry Eye Work Shop. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Work Shop. Ocul Surf. 2007;5:93–107. [DOI via Crossref]   
4. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264–8. [DOI via Crossref]    [Pubmed]   
5. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3(1):405–12. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
6. Gupta N, Sharma D, Garg SK, Bhargava VK. Auditing of prescriptions to study utilization of antimicrobials in tertiary hospital. Indian J Pharmacol. 1997;29:411–5.
7. Kapoor B, Raina RK, Kapoor S. Drug prescribing pattern in a teaching hospital. Indian J Pharmacol. 1985;17:168.
8. Pradhan SC, Shewade DG, Shashindran CH, Bapna JS. Drug utilization studies. Natl Med J India. 1988;1:185.
9. Yuen YH, Chang S, Chong CK, Lee SC, Critchlev JA, Chan JC. Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther. 1998;23:287–94. [DOI via Crossref]    [Pubmed]   
10. Tiwari H, Kumar A, Kulkarni SK. Prescription monitoring of antihypertensive drug utilization at the Panjab University Health Centre in India. Singapore Med J. 2004;45:117–20. [Pubmed]   
11. Sahai A, Malik P. Dry eye: prevalence and attributable risk factors in a hospital-based population. Indian J Ophthalmol. 2005;53: 87–91. [DOI via Crossref]    [Pubmed]   
12. Albietz JM. Prevalence of dry eye subtypes in clinical optometry practice. Optometry Vis Sci. 2000;77:357–63. [DOI via Crossref]   
13. Kaercher T, Buchholz P, Kimmich F. Treatment of patients with keratoconjunctivitis sicca with optive: results of a multicenter, open-label observational study in Germany. Clin Ophthalmol. 2009;3:33–9. [Pubmed]    [PMC Free Fulltext]   
14. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003; 136(2):318–26. [DOI via Crossref]   
15. Lee AJ, Lee J, Saw SM, Gazzard G, Koh D, Widjaja D, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol. 2002;86:1347–51. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
16. Akingbehin AO. Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%. Br J Ophthalmol. 1983;67:661–3. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
17. Sindt CW, Foulks GN. Efficacy of artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction. Clin Ophthalmol. 2013;7:1713–22. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
18. Yanai K, Huang J, Kadonosono K, Uchio E. Corneal sensitivity after topical bromofenac sodium eye drop instillation. Clin Ophthalmol. 2013;7:741–4. [Pubmed]    [PMC Free Fulltext]   
19. Nagelhout TJ, Gamache DA, Roberts L, Brady MT, Yanni JM. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye. J Ocu Pharmaco Ther. 2005;21 (2):139–48. [DOI via Crossref]    [Pubmed]   
20. Niederkorn JY, Stern ME, Pflugfelder SC, De Paiva CS, Corrales RM, Gao J. Desiccating stress induces T cell-mediated Sjogren's syndrome-like lacrimal keratoconjunctivitis. J Immunol. 2006;176 (7):3950–7. [DOI via Crossref]    [Pubmed]   
21. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105:1114–19. [DOI via Crossref]   
22. Gilbard JP. Dry-eye disorders In: Albert DM, Jakobiec FA, Azar DT, Gragoudas ES (Eds.), Principles and Practice of Ophthalmology, 2nd edn, New York: WB Saunders, 2000. pp. 982–1001.
23. Latkany R. Dry eyes: etiology and management. Curr Opin Ophthalmol. 2008;19(4):287–91. [DOI via Crossref]    [Pubmed]   
24. Cohen S, Martin A, Sall K. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethyl cellulose. Clin Ophthalmol. 2014;8:157–64. [Pubmed]    [PMC Free Fulltext]   
25. Kim TH, Kang JW, Kim KH, Kang KW, Shin MS, Jung SY, Kim AR. Acupuncture for the treatment of dry eye: a multicentre randomised controlled trial with active comparison intervention (artificial teardrops). PLoS One. 2012;7(5):1–9. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
26. Sandoval HP, Fernandez de Castro LE, Vroman DT, Solomon KD. A review of the use of ketorolac tromethamine 0.4% in the treatment of post-surgical inflammation following cataract and refractive surgery. Clin Ophthalmol. 2007;1(4):367–71. [Pubmed]    [PMC Free Fulltext]   
27. Schechter BA. Ketorolac during the induction phase of cyclosporin—a therapy. J Ocul Pharmacol Ther. 2006;22:150–4. [DOI via Crossref]    [Pubmed]   
28. Simone JN, Pendelton RA, Jenkins JE. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. J Cataract Refract Surg. 1999; 25:699–704. [DOI via Crossref]   
29. Aragona P, Stilo A, Ferreri F, Mobrici M. Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjogren's syndrome patients. Eye. 2005;19:535–9. [DOI via Crossref]    [Pubmed]   
30. Yanai K, Huang J, Kadonosono K, Uchio E. Corneal sensitivity after topical bromofenac sodium eye drop instillation. Clin ophthalmol. 2013;7:741–4. [Pubmed]    [PMC Free Fulltext]   
31. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res. 2006;82(5):885–98. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
32. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immune-cytochemical study. Am J Ophthalmol. 2003;136(4): 593–602. [DOI via Crossref]   
33. Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, et al. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004;138(3):444–57. [DOI via Crossref]    [Pubmed]   
34. World Health Organization (WHO) and International Network for Rational Use of Drugs. How to Investigate Drug Use in Health Facilities: Selected Drug Use indicators, WHO/DAP/93.1. Geneva: WHO, 1993.
35. Nehru M, Kohli K, Kapoor B, Sadhotra P, Chopra V, Sharma R. Drug utilization study in outpatient ophthalmology department of Government Medical College Jammu. JK Science. 2005;7(3):149–51.

How to Cite this Article
Pubmed Style

Shaktibala Dutta, Mirza Atif Beg, Shalu Bawa, Saubhagya Sindhu, Mohammad Anjoom, Sanjeev Kumar Mittal, Yogesh Kumar, Ankita Negi. Preferred drug usage among patients attending ophthalmology outpatient department for the treatment of dry eye syndrome in a tertiary care teaching hospital at Dehradun, Uttarakhand. Natl J Physiol Pharm Pharmacol. 2015; 5(3): 217-221. doi:10.5455/njppp.2015.5.1901201521


Web Style

Shaktibala Dutta, Mirza Atif Beg, Shalu Bawa, Saubhagya Sindhu, Mohammad Anjoom, Sanjeev Kumar Mittal, Yogesh Kumar, Ankita Negi. Preferred drug usage among patients attending ophthalmology outpatient department for the treatment of dry eye syndrome in a tertiary care teaching hospital at Dehradun, Uttarakhand. https://www.njppp.com/?mno=177956 [Access: June 02, 2022]. doi:10.5455/njppp.2015.5.1901201521


AMA (American Medical Association) Style

Shaktibala Dutta, Mirza Atif Beg, Shalu Bawa, Saubhagya Sindhu, Mohammad Anjoom, Sanjeev Kumar Mittal, Yogesh Kumar, Ankita Negi. Preferred drug usage among patients attending ophthalmology outpatient department for the treatment of dry eye syndrome in a tertiary care teaching hospital at Dehradun, Uttarakhand. Natl J Physiol Pharm Pharmacol. 2015; 5(3): 217-221. doi:10.5455/njppp.2015.5.1901201521



Vancouver/ICMJE Style

Shaktibala Dutta, Mirza Atif Beg, Shalu Bawa, Saubhagya Sindhu, Mohammad Anjoom, Sanjeev Kumar Mittal, Yogesh Kumar, Ankita Negi. Preferred drug usage among patients attending ophthalmology outpatient department for the treatment of dry eye syndrome in a tertiary care teaching hospital at Dehradun, Uttarakhand. Natl J Physiol Pharm Pharmacol. (2015), [cited June 02, 2022]; 5(3): 217-221. doi:10.5455/njppp.2015.5.1901201521



Harvard Style

Shaktibala Dutta, Mirza Atif Beg, Shalu Bawa, Saubhagya Sindhu, Mohammad Anjoom, Sanjeev Kumar Mittal, Yogesh Kumar, Ankita Negi (2015) Preferred drug usage among patients attending ophthalmology outpatient department for the treatment of dry eye syndrome in a tertiary care teaching hospital at Dehradun, Uttarakhand. Natl J Physiol Pharm Pharmacol, 5 (3), 217-221. doi:10.5455/njppp.2015.5.1901201521



Turabian Style

Shaktibala Dutta, Mirza Atif Beg, Shalu Bawa, Saubhagya Sindhu, Mohammad Anjoom, Sanjeev Kumar Mittal, Yogesh Kumar, Ankita Negi. 2015. Preferred drug usage among patients attending ophthalmology outpatient department for the treatment of dry eye syndrome in a tertiary care teaching hospital at Dehradun, Uttarakhand. National Journal of Physiology, Pharmacy and Pharmacology, 5 (3), 217-221. doi:10.5455/njppp.2015.5.1901201521



Chicago Style

Shaktibala Dutta, Mirza Atif Beg, Shalu Bawa, Saubhagya Sindhu, Mohammad Anjoom, Sanjeev Kumar Mittal, Yogesh Kumar, Ankita Negi. "Preferred drug usage among patients attending ophthalmology outpatient department for the treatment of dry eye syndrome in a tertiary care teaching hospital at Dehradun, Uttarakhand." National Journal of Physiology, Pharmacy and Pharmacology 5 (2015), 217-221. doi:10.5455/njppp.2015.5.1901201521



MLA (The Modern Language Association) Style

Shaktibala Dutta, Mirza Atif Beg, Shalu Bawa, Saubhagya Sindhu, Mohammad Anjoom, Sanjeev Kumar Mittal, Yogesh Kumar, Ankita Negi. "Preferred drug usage among patients attending ophthalmology outpatient department for the treatment of dry eye syndrome in a tertiary care teaching hospital at Dehradun, Uttarakhand." National Journal of Physiology, Pharmacy and Pharmacology 5.3 (2015), 217-221. Print. doi:10.5455/njppp.2015.5.1901201521



APA (American Psychological Association) Style

Shaktibala Dutta, Mirza Atif Beg, Shalu Bawa, Saubhagya Sindhu, Mohammad Anjoom, Sanjeev Kumar Mittal, Yogesh Kumar, Ankita Negi (2015) Preferred drug usage among patients attending ophthalmology outpatient department for the treatment of dry eye syndrome in a tertiary care teaching hospital at Dehradun, Uttarakhand. National Journal of Physiology, Pharmacy and Pharmacology, 5 (3), 217-221. doi:10.5455/njppp.2015.5.1901201521